Vident Investment Advisory, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 175 filers reported holding CARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$549,761
-29.8%
194,262
+21.9%
0.02%
-24.0%
Q1 2023$782,679
-42.4%
159,405
+25.9%
0.02%
-51.0%
Q4 2022$1,359,931
+12.5%
126,623
-2.0%
0.05%
+30.8%
Q3 2022$1,209,000
+9.8%
129,182
+7.1%
0.04%
+18.2%
Q2 2022$1,101,000
-16.1%
120,590
+11.7%
0.03%
-2.9%
Q1 2022$1,312,000
+75.4%
107,982
+75.9%
0.03%
+78.9%
Q4 2021$748,000
-17.9%
61,392
+4.1%
0.02%
-32.1%
Q3 2021$911,00058,9500.03%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders